Squarepoint Ops LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,923,505

-$3,860,960 QoQ

Shares Held

1,747,096

+16.0% QoQ

Ownership

5.56%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 143 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. LENZ ranks #33 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,923,505	1,747,096	+16.0%	Shares	Defined	2026-08-14
2026-04-01	$14,896,850	1,593,246	—	Shares	Sole	2026-04-08
2026-03-31	$13,784,465	1,506,499	+206.3%	Shares	Defined	2026-05-15
2025-12-31	$7,870,368	491,898	+447.8%	Shares	Defined	2026-02-13
2025-09-30	$4,182,325	89,788	+800.3%	Shares	Defined	2025-11-14
2025-06-30	$292,308	9,973	-64.3%	Shares	Defined	2025-08-27
2025-03-31	$718,208	27,935	+120.8%	Shares	Defined	2025-08-27
2024-09-30	$300,405	12,654	+20.8%	Shares	Defined	2024-11-14
2024-06-30	$181,147	10,477	—	Shares	Defined	2024-08-14
2023-12-31 GRPH	—	12,368	-12.4%	Shares	Defined	2024-02-14
2023-03-31 GRPH	—	14,113	+20.1%	Shares	Defined	2023-05-15
2022-06-30 GRPH	—	11,749	-70.6%	Shares	Defined	2022-08-15
2021-06-30 GRPH	—	40,000	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.